Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001104659-23-063213
Filing Date
2023-05-22
Accepted
2023-05-22 17:01:08
Documents
15
Reference 429
333-271549

Document Format Files

Seq Description Document Type Size
1 F-3 tm2316412-1_f3.htm F-3 597123
2 EXHIBIT 4.10 tm2316412d2_ex4-10.htm EX-4.10 341848
3 EXHIBIT 5.1 tm2316412d2_ex5-1.htm EX-5.1 53867
4 EXHIBIT 5.2 tm2316412d2_ex5-2.htm EX-5.2 18501
5 EXHIBIT 23.2 tm2316412d2_ex23-2.htm EX-23.2 3323
6 EXHIBIT 23.3 tm2316412d2_ex23-3.htm EX-23.3 2271
7 EXHIBIT 23.4 tm2316412d2_ex23-4.htm EX-23.4 6708
8 EX-FILING FEES tm2316412d2_ex-filingfees.htm EX-FILING FEES 70513
9 GRAPHIC lg_belite-4clr.jpg GRAPHIC 13168
10 GRAPHIC fc_organization-bwlr.jpg GRAPHIC 132099
11 GRAPHIC tm2316412d2_ex5-1img01.jpg GRAPHIC 10036
12 GRAPHIC tm2316412d12_ex23-4img02.jpg GRAPHIC 10750
13 GRAPHIC tm2316412d2_ex23-2img001.jpg GRAPHIC 44459
14 GRAPHIC tm2316412d2_ex23-2img002.jpg GRAPHIC 34504
15 GRAPHIC tm2316412d2_ex5-2img01.jpg GRAPHIC 9817
  Complete submission text file 0001104659-23-063213.txt   1427082
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-272125 | Film No.: 23945395
SIC: 2834 Pharmaceutical Preparations